|
|
Gene Symbol |
AKT1 |
|
Aliases |
AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA |
|
Entrez Gene ID |
|
|
Gene Name |
AKT serine/threonine kinase 1 |
|
Chromosomal Location |
14q32.33 |
|
HGNC ID |
|
|
Summary |
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
Gene |
|
|
Transcript |
ENST00000554581, ENST00000407796, ENST00000349310, ENST00000402615, ENST00000555528, ENST00000649815, ENST00000555458, ENST00000554192, ENST00000554585, ENST00000554848, ENST00000555926 |
|
Protein |
ENSP00000451828, ENSP00000384293, ENSP00000270202, ENSP00000385326, ENSP00000450688, ENSP00000497822, ENSP00000451470, ENSP00000450681, ENSP00000481526, ENSP00000451166, ENSP00000451824
|
|
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001934 |
Biological process |
Positive regulation of protein phosphorylation |
IDA |
19057511 |
GO:0001938 |
Biological process |
Positive regulation of endothelial cell proliferation |
IMP |
19850054 |
GO:0002042 |
Biological process |
Cell migration involved in sprouting angiogenesis |
IMP |
28341552 |
GO:0005979 |
Biological process |
Regulation of glycogen biosynthetic process |
IMP |
8940145 |
GO:0006464 |
Biological process |
Cellular protein modification process |
TAS |
10570282 |
GO:0006468 |
Biological process |
Protein phosphorylation |
IDA |
11994271, 14749367, 23431171 |
GO:0006469 |
Biological process |
Negative regulation of protein kinase activity |
IMP |
9373175 |
GO:0006606 |
Biological process |
Protein import into nucleus |
IMP |
16280327 |
GO:0006809 |
Biological process |
Nitric oxide biosynthetic process |
TAS |
10376602 |
GO:0006924 |
Biological process |
Activation-induced cell death of T cells |
IMP |
14749367 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
21432781 |
GO:0007173 |
Biological process |
Epidermal growth factor receptor signaling pathway |
IDA |
20878056 |
GO:0007186 |
Biological process |
G protein-coupled receptor signaling pathway |
TAS |
10570282 |
GO:0007249 |
Biological process |
I-kappaB kinase/NF-kappaB signaling |
IMP |
26514923 |
GO:0008283 |
Biological process |
Cell proliferation |
TAS |
21432781 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IMP |
10983986 |
GO:0008286 |
Biological process |
Insulin receptor signaling pathway |
IMP |
8978681 |
GO:0009408 |
Biological process |
Response to heat |
TAS |
10958679 |
GO:0010507 |
Biological process |
Negative regulation of autophagy |
IMP |
18387192 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
28341552 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
ISS |
18292230 |
GO:0010748 |
Biological process |
Negative regulation of plasma membrane long-chain fatty acid transport |
IMP |
16814735 |
GO:0010907 |
Biological process |
Positive regulation of glucose metabolic process |
IMP |
16814735 |
GO:0010918 |
Biological process |
Positive regulation of mitochondrial membrane potential |
IMP |
10983986 |
GO:0010951 |
Biological process |
Negative regulation of endopeptidase activity |
IMP |
18387192 |
GO:0014065 |
Biological process |
Phosphatidylinositol 3-kinase signaling |
IMP |
26514923 |
GO:0016242 |
Biological process |
Negative regulation of macroautophagy |
NAS |
23778976 |
GO:0016310 |
Biological process |
Phosphorylation |
IDA |
20333297 |
GO:0018105 |
Biological process |
Peptidyl-serine phosphorylation |
IBA |
21873635 |
GO:0018105 |
Biological process |
Peptidyl-serine phosphorylation |
IDA |
16139227 |
GO:0018105 |
Biological process |
Peptidyl-serine phosphorylation |
TAS |
21711983 |
GO:0018107 |
Biological process |
Peptidyl-threonine phosphorylation |
IDA |
20605787 |
GO:0030154 |
Biological process |
Cell differentiation |
TAS |
21432781 |
GO:0030307 |
Biological process |
Positive regulation of cell growth |
IDA |
19203586 |
GO:0030334 |
Biological process |
Regulation of cell migration |
IMP |
19934221 |
GO:0030334 |
Biological process |
Regulation of cell migration |
TAS |
21432781 |
GO:0031397 |
Biological process |
Negative regulation of protein ubiquitination |
IMP |
18292230 |
GO:0031929 |
Biological process |
TOR signaling |
NAS |
23778976 |
GO:0031999 |
Biological process |
Negative regulation of fatty acid beta-oxidation |
IMP |
16814735 |
GO:0032079 |
Biological process |
Positive regulation of endodeoxyribonuclease activity |
IDA |
20605787 |
GO:0032091 |
Biological process |
Negative regulation of protein binding |
IMP |
18292230 |
GO:0032869 |
Biological process |
Cellular response to insulin stimulus |
IMP |
16814735 |
GO:0033138 |
Biological process |
Positive regulation of peptidyl-serine phosphorylation |
IDA |
19667065 |
GO:0034405 |
Biological process |
Response to fluid shear stress |
IMP |
10376603 |
GO:0034614 |
Biological process |
Cellular response to reactive oxygen species |
IMP |
26514923 |
GO:0035556 |
Biological process |
Intracellular signal transduction |
IBA |
21873635 |
GO:0035556 |
Biological process |
Intracellular signal transduction |
IDA |
14749367 |
GO:0035655 |
Biological process |
Interleukin-18-mediated signaling pathway |
IDA |
21321938 |
GO:0038061 |
Biological process |
NIK/NF-kappaB signaling |
IMP |
26514923 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
IDA |
19203586 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
IMP |
10983986 |
GO:0043276 |
Biological process |
Anoikis |
NAS |
23778976 |
GO:0043491 |
Biological process |
Protein kinase B signaling |
IMP |
28341552 |
GO:0043536 |
Biological process |
Positive regulation of blood vessel endothelial cell migration |
IDA |
20011604 |
GO:0045429 |
Biological process |
Positive regulation of nitric oxide biosynthetic process |
IMP |
10376603 |
GO:0045600 |
Biological process |
Positive regulation of fat cell differentiation |
IMP |
8940145 |
GO:0045725 |
Biological process |
Positive regulation of glycogen biosynthetic process |
IMP |
16814735 |
GO:0045725 |
Biological process |
Positive regulation of glycogen biosynthetic process |
NAS |
17925406 |
GO:0045737 |
Biological process |
Positive regulation of cyclin-dependent protein serine/threonine kinase activity |
IMP |
18483258 |
GO:0045861 |
Biological process |
Negative regulation of proteolysis |
IMP |
18387192 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IMP |
26514923 |
GO:0046326 |
Biological process |
Positive regulation of glucose import |
IMP |
8940145, 16814735 |
GO:0046777 |
Biological process |
Protein autophosphorylation |
TAS |
16280327 |
GO:0046889 |
Biological process |
Positive regulation of lipid biosynthetic process |
IMP |
8940145 |
GO:0048009 |
Biological process |
Insulin-like growth factor receptor signaling pathway |
IMP |
8978681 |
GO:0048661 |
Biological process |
Positive regulation of smooth muscle cell proliferation |
IDA |
21321938 |
GO:0051000 |
Biological process |
Positive regulation of nitric-oxide synthase activity |
IMP |
10376603 |
GO:0051091 |
Biological process |
Positive regulation of DNA-binding transcription factor activity |
IDA |
19057511 |
GO:0060079 |
Biological process |
Excitatory postsynaptic potential |
NAS |
21711983 |
GO:0060644 |
Biological process |
Mammary gland epithelial cell differentiation |
TAS |
21432781 |
GO:0070141 |
Biological process |
Response to UV-A |
IDA |
18483258 |
GO:0071276 |
Biological process |
Cellular response to cadmium ion |
IMP |
26514923 |
GO:0071356 |
Biological process |
Cellular response to tumor necrosis factor |
IMP |
10983986 |
GO:0071901 |
Biological process |
Negative regulation of protein serine/threonine kinase activity |
TAS |
28386764 |
GO:0072655 |
Biological process |
Establishment of protein localization to mitochondrion |
IMP |
23962723 |
GO:0072656 |
Biological process |
Maintenance of protein location in mitochondrion |
IMP |
23962723 |
GO:0100002 |
Biological process |
Negative regulation of protein kinase activity by protein phosphorylation |
TAS |
21711983 |
GO:0140052 |
Biological process |
Cellular response to oxidised low-density lipoprotein particle stimulus |
IMP |
28341552 |
GO:1900087 |
Biological process |
Positive regulation of G1/S transition of mitotic cell cycle |
IMP |
18483258 |
GO:1900182 |
Biological process |
Positive regulation of protein localization to nucleus |
IMP |
20605787 |
GO:1901215 |
Biological process |
Negative regulation of neuron death |
NAS |
18221368 |
GO:1902176 |
Biological process |
Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
NAS |
16604263 |
GO:1903038 |
Biological process |
Negative regulation of leukocyte cell-cell adhesion |
IMP |
28341552 |
GO:1903078 |
Biological process |
Positive regulation of protein localization to plasma membrane |
IMP |
8940145 |
GO:1903721 |
Biological process |
Positive regulation of I-kappaB phosphorylation |
IMP |
26514923 |
GO:1990090 |
Biological process |
Cellular response to nerve growth factor stimulus |
IMP |
20605787 |
GO:2000402 |
Biological process |
Negative regulation of lymphocyte migration |
IMP |
28341552 |
GO:2001240 |
Biological process |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
TAS |
10748004 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
20333297 |
GO:0005634 |
Cellular component |
Nucleus |
TAS |
21432781 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
19203586, 25190803 |
GO:0005737 |
Cellular component |
Cytoplasm |
TAS |
21432781 |
GO:0005829 |
Cellular component |
Cytosol |
IDA |
21045808 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
14749367, 19203586, 20333297 |
GO:0005886 |
Cellular component |
Plasma membrane |
TAS |
21432781 |
GO:0031982 |
Cellular component |
Vesicle |
IDA |
16792529 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
10983986, 20878056 |
GO:0004672 |
Molecular function |
Protein kinase activity |
TAS |
10570282 |
GO:0004674 |
Molecular function |
Protein serine/threonine kinase activity |
EXP |
17030608 |
GO:0004674 |
Molecular function |
Protein serine/threonine kinase activity |
IBA |
21873635 |
GO:0004674 |
Molecular function |
Protein serine/threonine kinase activity |
IDA |
10102273, 10983986, 11994271, 16139227, 16540465, 19667065 |
GO:0004674 |
Molecular function |
Protein serine/threonine kinase activity |
NAS |
28386764 |
GO:0004674 |
Molecular function |
Protein serine/threonine kinase activity |
TAS |
21432781, 21711983 |
GO:0004712 |
Molecular function |
Protein serine/threonine/tyrosine kinase activity |
IDA |
22797923 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
10102273, 10983986, 11154276, 11438723, 11839802, 12176997, 12244133, 12791994, 16044149, 16139227, 16280327, 16282323, 16417524, 16525023, 16537421, 16792529, 17006541, 17577629, 17932490, 18191226, 18250332, 18292230, 18505846, 18562279, 18624398, 18650932, 18786403, 19162005, 191 |
GO:0005516 |
Molecular function |
Calmodulin binding |
IDA |
29104511 |
GO:0005524 |
Molecular function |
ATP binding |
IC |
11994271 |
GO:0005524 |
Molecular function |
ATP binding |
IDA |
16540465 |
GO:0005547 |
Molecular function |
Phosphatidylinositol-3,4,5-trisphosphate binding |
IDA |
19203586 |
GO:0016301 |
Molecular function |
Kinase activity |
IDA |
14749367 |
GO:0030235 |
Molecular function |
Nitric-oxide synthase regulator activity |
IMP |
10376603 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
7891724, 17554339 |
GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
10983986 |
GO:0043325 |
Molecular function |
Phosphatidylinositol-3,4-bisphosphate binding |
IDA |
19203586 |
GO:0071889 |
Molecular function |
14-3-3 protein binding |
IPI |
10102273 |
|
Protein Information |
|
Protein Name |
RAC-alpha serine/threonine-protein kinase, AKT1m, PKB alpha, RAC-PK-alpha, protein kinase B alpha, proto-oncogene c-Akt, rac protein kinase alpha, serine-threonine protein kinase, v-akt murine thymoma viral oncogene homolog 1, v-akt murine thymoma viral oncogene-like protein 1 |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
1H10, 1UNP, 1UNQ, 1UNR, 2UVM, 2UZR, 2UZS, 3CQU, 3CQW, 3MV5, 3MVH, 3O96, 3OCB, 3OW4, 3QKK, 3QKL, 3QKM, 4EJN, 4EKK, 4EKL, 4GV1, 5KCV, 6BUU, 6CCY, 6HHF, 6HHG, 6HHH, 6HHI, 6HHJ, 6NPZ |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000331746 |
P01258 |
P01258 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Cardiomyopathy |
|
Myocardial Diseases |
|
Aortic valve calcification |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Proteus syndrome |
|
Digestive System Diseases |
Intestinal Polyposis |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Breast Cancer |
17611497, 20228224, 20453058, 19418217, 22538770, 22722201, 26619011, 23237847, 19487299, 25157968, 21464312, 21512767, 21793738 |
Meningioma |
|
Endometrial Cancer |
|
Bladder Cancer |
|
Lung Cancer |
21911043, 22619562, 12511591, 26619011, 25157968, 17611497, 23728071, 18504432, 18611285, 22980975, 24657128 |
Colorectal Cancer |
|
Skin Cancer |
|
Ovarian Cancer |
|
Prostate cancer |
|
Breast Cancer,Male |
|
Proteus Syndrome |
|
Liver Cancer |
|
Osteosarcoma |
|
Hamartoma |
|
Lymphoma |
|
Colonic Neoplasms |
|
Thyroid Cancer |
|
Carcinoma |
|
Intestinal Polyposis |
|
Ctaneous Melanoma |
|
Adenocarcinoma of Prostate |
|
Leukemia |
|
Head Neoplasms |
|
Gastric Cancer |
|
Vulvar Cancer |
|
Nervous System Diseases |
Epilepsy |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Psychiatric/Brain disorders |
Schizophrenia |
|
Bipolar Disorder |
|
Intellectual Disability |
|
Mental Depression |
|
Mood Disorders |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
PI3K |
Endometrial hyperplasia and carcinoma |
|
|
Related
|
|
The PI3K/Akt pathway was over activated in endometrium with PCOS which may be associated with the formation of endometrial hyperplasia and carcinoma in PCOS patients. |
|
CDK2, Cyclin E, p27 and Ras |
Hyperplasia |
Ser473-AKT phosphorylation |
Rotterdam criteria |
Related
|
|
The PCOS condition is associated with increased Ser473-AKT phosphorylation, elevated expression of Ras, increased cytoplasmic abundance of p27, and increased nuclear abundance of CDK2 in the endometrial epithelial cells. These biological events could potentially provide a chance for endometrial cells from PCOS patients to exit the controlled cell cycle and become hyperplastic at a later stage |
|
|
|
|